YAP1 and hepatocellular carcinoma: USP47 enhances YAP1 stability in colorectal cancer and correlates with poor prognosis,107 whereas circRNAs and m6A modifications, particularly those mediated by METTL3—orchestrate YAP1 expression in hepatocellular carcinoma to drive vasculogenic mimicry and drug resistance.108